TAU BIO-LOGIC Announces Humanization of Picomolar Affinity Mon...
NEW YORK and LONDON, April 18, 2019 /PRNewswire-AsiaNet/ -- TAU BIO-LOGIC CORP. announced today that in collaboration with the UK-based group LifeArc, it has successfully humanized a monoclonal antibody (TBL-100) that targets C-terminally truncated tau (tauC3).TAU BIO-LOGIC is developing TBL-100 for the ...
Authors: LATEST ASIANET NEWS RELEASES